Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery

References

• Constantinou C, Papas A, Constantinou AI. Vitamin E and cancer: an insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer. 2008;123:739–752.
   PubMed Web of Science ®Google Scholar
• Constantinides PP, Han J, Davis SS. Advances in the use of tocols as drug delivery vehicles. Pharm Res. 2006;23:243–255.
   PubMed Web of Science ®Google Scholar
• Cooney RV, Franke AA, Harwood PJ, et al. Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc Natl Acad Sci U S A. 1993;90:1771–1775.
   PubMed Web of Science ®Google Scholar
• Grammas P, Hamdheydari L, Benaksas EJ, et al. Anti-inflammatory effects of tocopherol metabolites. Biochem Biophys Res Commun. 2004;319:1047–1052.
   PubMed Web of Science ®Google Scholar
• Yu W, Simmons-Menchaca M, Gapor A, et al. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr Cancer. 1999;33:26–32.
   PubMed Web of Science ®Google Scholar
• Berrino F, Muti P. Mediterranean diet and cancer. Eur J Clin Nutr. 1989;43(Suppl 2):49–55.
   PubMedGoogle Scholar
• Eichholzer M, Stähelin HB, Gey KF, et al. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer. 1996;66:145–150.
   PubMed Web of Science ®Google Scholar
• Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90:440–446.
   PubMed Web of Science ®Google Scholar
• Wright ME, Weinstein SJ, Lawson KA, et al. Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2007;16:1128–1135.
   PubMed Web of Science ®Google Scholar
• Kune G, Watson L. Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B6, B12, C, E, selenium, and lycopene. Nutr Cancer. 2006;56:11–21.
   PubMed Web of Science ®Google Scholar
• Miyazawa T, Shibata A, Sookwong P, et al. Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol). J Nutr Biochem. 2009;20:79–86.
   PubMed Web of Science ®Google Scholar
• Ling MT, Luk SU, Al-Ejeh F, et al. Tocotrienol as a potential anticancer agent. Carcinogenesis. 2012;33:233–239.
   PubMed Web of Science ®Google Scholar
• Yano T, Sato A, Sekine M, et al. Redox-inactive analogue of tocotrienol as a potential anti-cancer agent. Anticancer Agents Med Chem. 2013;13:496–501.
   PubMed Web of Science ®Google Scholar
• Sylvester PW, Ayoub NM. Tocotrienols target PI3K/Akt signaling in anti-breast cancer therapy. Anticancer Agents Med Chem. 2013;13:1039–1047.
   PubMed Web of Science ®Google Scholar
• Angulo-Molina A, Reyes-Leyva J, López-Malo A, et al. The role of alpha tocopheryl succinate (alpha-TOS) as a potential anticancer agent. Nutr Cancer. 2014;66:167–176.
   PubMed Web of Science ®Google Scholar
• Neuzil J, Tomasetti M, Mellick AS, et al. Vitamin E analogues: a new class of inducers of apoptosis with selective anti-cancer effects. Curr Cancer Drug Targets. 2004;4:355–372.
   PubMed Web of Science ®Google Scholar
• Azzi A, Aratri E, Boscoboinik D, et al. Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation. Biofactors. 1998;7:3–14.
   PubMed Web of Science ®Google Scholar
• Pastori M, Pfander H, Boscoboinik D, et al. Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells. Biochem Biophys Res Commun. 1998;250:582–585.
   PubMed Web of Science ®Google Scholar
• Campbell SE, Stone WL, Lee S, et al. Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell lines. BMC Cancer. 2006;6:13.
   PubMed Web of Science ®Google Scholar
• Gysin R, Azzi A, Visarius T. Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J. 2002;16:1952–1954.
   PubMed Web of Science ®Google Scholar
• Neuzil J. Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity. Br J Cancer. 2003;89:1822–1826.
   PubMed Web of Science ®Google Scholar
• Neuzil J, Weber T, Gellert N, et al. Selective cancer cell killing by alpha-tocopheryl succinate. Br J Cancer. 2001;84:87–89.
   PubMed Web of Science ®Google Scholar
• Schwartz J, Shklar G. The selective cytotoxic effect of carotenoids and alpha-tocopherol on human cancer cell lines in vitro. J Oral Maxillofac Surg. 1992;50:367–374.
   PubMed Web of Science ®Google Scholar
• Kline K, Yu W, Sanders BG, et al. mechanisms of action as tumor cell growth inhibitors. J Nutr. 2001;131:161S–163S.
   PubMed Web of Science ®Google Scholar
• Yu W, Liao QY, Hantash FM, et al. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells. Cancer Res. 2001;61:6569–6576.
   PubMed Web of Science ®Google Scholar
• Turánek J, Wang X-F, Knötigová P, et al. Liposomal formulation of alpha-tocopheryl maleamide: in vitro and in vivo toxicological profile and anticancer effect against spontaneous breast carcinomas in mice. Toxicol Appl Pharmacol. 2009;237:249–257.
   PubMed Web of Science ®Google Scholar
• Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1. Nutr Cancer. 2002;43:227–236.
   PubMed Web of Science ®Google Scholar
• Alleva R, Benassi MS, Pazzaglia L, et al. Alpha-tocopheryl succinate alters cell cycle distribution sensitising human osteosarcoma cells to methotrexate-induced apoptosis. Cancer Lett. 2006;232:226–235.
   PubMed Web of Science ®Google Scholar
• Ni J, Chen M, Zhang Y, et al. Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery. Biochem Biophys Res Commun. 2003;300:357–363.
   PubMed Web of Science ®Google Scholar
• Wu K, Li Y, Zhao Y, et al. Roles of Fas signaling pathway in vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells. World J Gastroenterol. 2002;8:982–986.
   PubMed Web of Science ®Google Scholar
• Kang Y-H, Lee E, Youk H-J, et al. Potentiation by alpha-tocopheryl succinate of the etoposide response in multidrug resistance protein 1-expressing glioblastoma cells. Cancer Lett. 2005;217:181–190.
   PubMed Web of Science ®Google Scholar
• Guo Y, Luo J, Tan S, et al. The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci. 2013;49:175–186.
   PubMed Web of Science ®Google Scholar
• Duhem N, Danhier F, Préat V. Vitamin E-based nanomedicines for anti-cancer drug delivery. J Control Release. 2014;182:33–44.
   PubMed Web of Science ®Google Scholar
• Neophytou CM, Constantinou AI. Drug delivery innovations for enhancing the anticancer potential of vitamin E isoforms and their derivatives. Biomed Res Int. 2015;2015:1–16.
   Web of Science ®Google Scholar
• Youk H-J, Lee E, Choi M-K, et al. Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol. J Control Release. 2005;107:43–52.
   PubMed Web of Science ®Google Scholar
• Wang D-F, Rong W-T, Lu Y, et al. TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells. ACS Appl Mater Interfaces. 2015;7:3888–3901.
   PubMed Web of Science ®Google Scholar
• Bao Y, Guo Y, Zhuang X, et al. D-alpha-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol Pharm. 2014;11:3196–3209.
   PubMed Web of Science ®Google Scholar
• Zhu H, Chen H, Zeng X, et al. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials. 2014;35:2391–2400.
   PubMed Web of Science ®Google Scholar
• Guo Y, Chu M, Tan S, et al. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Mol Pharm. 2014;11:59–70.
   PubMed Web of Science ®Google Scholar
• Collnot E-M, Baldes C, Wempe MF, et al. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. Mol Pharm. 2007;4:465–474.
   PubMed Web of Science ®Google Scholar
• Collnot E-M, Baldes C, Wempe MF, et al. Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. J Control Release. 2006;111:35–40.
   PubMed Web of Science ®Google Scholar
• Biswas S, Torchilin VP. Nanopreparations for organelle-specific delivery in cancer. Adv Drug Deliv Rev. 2014;66:26–41.
   PubMed Web of Science ®Google Scholar
• Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. J Drug Target. 2016;24:179–191.
   PubMed Web of Science ®Google Scholar
• Biswas S, Kumari P, Lakhani PM, et al. Recent advances in polymeric micelles for anti-cancer drug delivery. Eur J Pharm Sci. 2016;83:184–202.
   PubMed Web of Science ®Google Scholar
• Tan S, Wu T, Zhang D, et al. Cell or cell membrane-based drug delivery systems. Theranostics. 2015;5:863–881.
   PubMed Web of Science ®Google Scholar
• Gao W, Zhang L. Coating nanoparticles with cell membranes for targeted drug delivery. J Drug Target. 2015;23:619–626.
   PubMed Web of Science ®Google Scholar
• Meyer RA, Sunshine JC, Green JJ. Biomimetic particles as therapeutics. Trends Biotechnol. 2015;33:514–524.
   PubMed Web of Science ®Google Scholar
• Tan S, Li X, Guo Y, et al. Lipid-enveloped hybrid nanoparticles for drug delivery. Nanoscale. 2013;5:860–872.
   PubMed Web of Science ®Google Scholar
• Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev. 2011;63:131–135.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev. 2006;58:1532–1555.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Passive and active drug targeting: drug delivery to tumors as an example. Handb Exp Pharmacol. 2010;3–53.
   PubMedGoogle Scholar
• Shi C, Zhang Z, Shi J, et al. Co-delivery of docetaxel and chloroquine via PEO-PPO-PCL/TPGS micelles for overcoming multidrug resistance. Int J Pharm. 2015;495:932–939.
   PubMed Web of Science ®Google Scholar
• Assanhou AG, Li W, Zhang L, et al. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Biomaterials. 2015;73:284–295.
   PubMed Web of Science ®Google Scholar
• Nielsen PB, Müllertz A, Norling T, et al. The effect of alpha-tocopherol on the in vitro solubilisation of lipophilic drugs. Int J Pharm. 2001;222:217–224.
   PubMed Web of Science ®Google Scholar
• Abouzeid AH, Patel NR, Torchilin VP. Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer. Int J Pharm. 2014;464:178–184.
   PubMed Web of Science ®Google Scholar
• Jin Y, Zhang Z, Zhao T, et al. Mixed micelles of doxorubicin overcome multidrug resistance by inhibiting the expression of P-glycoprotein. J Biomed Nanotechnol. 2015;11:1330–1338.
   PubMed Web of Science ®Google Scholar
• Danhier F, Kouhe TT, Duhem N, et al. Vitamin E-based micelles enhance the anticancer activity of doxorubicin. Int J Pharm. 2014;476:9–15.
   PubMed Web of Science ®Google Scholar
• Chandran T, Katragadda U, Teng Q, et al. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG). Int J Pharm. 2010;392:170–177.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li Y, Fang X, et al. TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy. Int J Pharm. 2014;476:185–198.
   PubMed Web of Science ®Google Scholar
• Gao Y, Li LB, Zhai G. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloids Surf B Biointerfaces. 2008;64:194–199.
   PubMed Web of Science ®Google Scholar
• Huang W, Wang X, Shi C, et al. Fine-tuning vitamin E-containing telodendrimers for efficient delivery of gambogic acid in colon cancer treatment. Mol Pharm. 2015;12:1216–1229.
   PubMed Web of Science ®Google Scholar
• Cheng X, Yan H, Jia X, et al. Preparation and in vivo/in vitro evaluation of formononetin phospholipid/vitamin E TPGS micelles. J Drug Target. 2016;24:161–168.
   PubMed Web of Science ®Google Scholar
• Sawant RR, Sawant RM, Torchilin VP. Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity. Eur J Pharm Biopharm. 2008;70:51–57.
   PubMed Web of Science ®Google Scholar
• Li Y, Lin J, Wu H, et al. Orthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effect. Mol Pharm. 2015;12:769–782.
   PubMed Web of Science ®Google Scholar
• De Melo-Diogo D, Gaspar VM, Costa EC, et al. Combinatorial delivery of Crizotinib-Palbociclib-Sildenafil using TPGS-PLA micelles for improved cancer treatment. Eur J Pharm Biopharm. 2014;88:718–729.
   PubMed Web of Science ®Google Scholar
• Emami J, Rezazadeh M, Rostami M, et al. Co-delivery of paclitaxel and alpha-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy. Drug Dev Ind Pharm. 2015;41:1137–1147.
   PubMed Web of Science ®Google Scholar
• Wang J, Cui S, Bao Y, et al. Tocopheryl pullulan-based self assembling nanomicelles for anti-cancer drug delivery. Mater Sci Eng C. 2014;43:614–621.
   PubMed Web of Science ®Google Scholar
• Saxena V, Hussain MD. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer. J Biomed Nanotechnol. 2013;9:1146–1154.
   PubMed Web of Science ®Google Scholar
• Wang Y, Fan W, Dai X, et al. Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles. Mol Pharm. 2014;11:1140–1150.
   PubMed Web of Science ®Google Scholar
• Pooja D, Kulhari H, Singh MK, et al. Dendrimer-TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes. Colloids Surf B Biointerfaces. 2014;121:461–468.
   PubMed Web of Science ®Google Scholar
• Qiu L, Qiao M, Chen Q, et al. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Biomaterials. 2014;35:9877–9887.
   PubMed Web of Science ®Google Scholar
• Wang S, Chen R, Morott J, et al. mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer. Expert Opin Drug Deliv. 2015;12:361–373.
   PubMed Web of Science ®Google Scholar
• Fan Z, Chen C, Pang X, et al. Adding vitamin E-TPGS to the formulation of Genexol-PM: specially mixed micelles improve drug-loading ability and cytotoxicity against multidrug-resistant tumors significantly. PLoS One. 2015;10:e0120129.
   PubMed Web of Science ®Google Scholar
• Jiang Z-M, Dai S-P, Xu Y-Q, et al. Crizotinib-loaded polymeric nanoparticles in lung cancer chemotherapy. Med Oncol. 2015;32:193.
   PubMed Web of Science ®Google Scholar
• Lu J, Huang Y, Zhao W, et al. Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel. Mol Pharm. 2013;10:2880–2890.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang Y, Zhao W, et al. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity. AAPS J. 2014;16:1282–1291.
   PubMed Web of Science ®Google Scholar
• Lu J, Zhao W, Liu H, et al. An improved d-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance. J Control Release. 2014;196:272–286.
   PubMed Web of Science ®Google Scholar
• Yu P, Yu H, Guo C, et al. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles. Acta Biomater. 2015;14:115–124.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhou Y, Wang D, et al. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(d,l-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor. Acta Biomater. 2015;17:182–192.
   PubMed Web of Science ®Google Scholar
• Zhao S, Tan S, Guo Y, et al. pH-sensitive docetaxel-loaded D-alpha-tocopheryl polyethylene glycol succinate-poly(beta-amino ester) copolymer nanoparticles for overcoming multidrug resistance. Biomacromolecules. 2013;14:2636–2646.
   PubMed Web of Science ®Google Scholar
• Xu P, Yu H, Zhang Z, et al. Hydrogen-bonded and reduction-responsive micelles loading atorvastatin for therapy of breast cancer metastasis. Biomaterials. 2014;35:7574–7587.
   PubMed Web of Science ®Google Scholar
• Ai X, Sun J, Zhong L, et al. Star-shape redox-responsive PEG-sheddable copolymer of disulfide-linked polyethylene glycol-lysine-di-tocopherol succinate for tumor-triggering intracellular doxorubicin rapid release: head-to-head comparison. Macromol Biosci. 2014;14:1415–1428.
   PubMed Web of Science ®Google Scholar
• Fan W, Wang Y, Dai X, et al. Reduction-responsive crosslinked micellar nanoassemblies for tumor-targeted drug delivery. Pharm Res. 2014;32:1325–1340.
   PubMed Web of Science ®Google Scholar
• Xu P, Meng Q, Sun H, et al. Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer. Biomaterials. 2015;64:10–20.
   PubMed Web of Science ®Google Scholar
• Zhao J, Mi Y, Feng S-S. Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles. Biomaterials. 2013;34:3411–3421.
   PubMed Web of Science ®Google Scholar
• Kutty RV, Feng S-S. Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers. Biomaterials. 2013;34:10160–10171.
   PubMed Web of Science ®Google Scholar
• Kutty RV, Chia SL, Setyawati MI, et al. In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer. Biomaterials. 2015;63:58–69.
   PubMed Web of Science ®Google Scholar
• Abouzeid AH, Patel NR, Sarisozen C, et al. Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells. Pharm Res. 2014;31:1938–1945.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kutty RV, Luo Z, et al. Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters. Biomaterials. 2015;39:234–248.
   PubMed Web of Science ®Google Scholar
• Sonali, Agrawal P, Singh RP, et al. Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Deliv. 2015;23:1–11.
   Web of Science ®Google Scholar
• Butt AM, Mohd Amin MCI, Katas H. Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs. Int J Nanomed. 2015;10:1321–1334.
   PubMed Web of Science ®Google Scholar
• Mi Y, Liu Y, Feng S-S. Formulation of docetaxel by folic acid-conjugated d-alpha-tocopheryl polyethylene glycol succinate 2000 (vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. Biomaterials. 2011;32:4058–4066.
   PubMed Web of Science ®Google Scholar
• Zhao H, Yung LY. Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting. J Biomed Mater Res A. 2009;91:505–518.
   PubMed Web of Science ®Google Scholar
• Munyendo WL, Zhang Z, Abbad S, et al. Micelles of TPGS modified apigenin phospholipid complex for oral administration: preparation, in vitro and in vivo evaluation. J Biomed Nanotechnol. 2013;9:2034–2047.
   PubMed Web of Science ®Google Scholar
• Lu J, Liu C, Wang P, et al. The self-assembling camptothecin-tocopherol prodrug: an effective approach for formulating camptothecin. Biomaterials. 2015;62:176–187.
   PubMed Web of Science ®Google Scholar
• Song Q, Tan S, Zhuang X, et al. Nitric oxide releasing d-alpha-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin. Mol Pharm. 2014;11:4118–4129.
   PubMed Web of Science ®Google Scholar
• Lee K-Y, Chiang Y-T, Hsu N-Y, et al. Vitamin E containing polymer micelles for reducing normal cell cytotoxicity and enhancing chemotherapy efficacy. Acta Biomater. 2015;24:286–296.
   PubMed Web of Science ®Google Scholar